Relafen 750, chemically known as naproxen, represents a significant case study from a biochemical pharmacy standpoint. This exhibits its pain-relieving effect primarily by blocking the activity of cyclooxygenase (COX) enzymes, specifically COX-2, thereby decreasing prostaglandin production . The selective inhibition of COX-2, compared to older NSAI